🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

PCI is effective at reducing angina when the target coronary lesion is responsible for angina. Sounds obvious, but bears repeating because of the implications: This is a DIAGNOSTIC problem, not a therapeutic one. We don't have a perfect test linking symptoms to disease.

Interventional cardiology does not alone bear the burden of solving our diagnostic limitations. Making ICs the scape goats has been popular, but this has alwasy been a challenge for all of cardiology, not one subspecialty.

Humbling findings to end a controversial year: we continue to fail our PAD pts, esp those at greatest need.  We have to join as a vascular community, no matter speciality or site of service. Hoping for greater collaborations & bending the amp curve in '24. rb.gy/o56x09

We had the pleasure of having Navin Kapur at OHSU Knight Cardio discussing cases, sharing pearls, and career advice with us! ✨Shoutout to our third-year fellow (and future IC) Omar Sheikh for presenting and Jeffrey Marbach for organizing✨

David J. Cohen, MD, MSc WEBodenMD Coronary 4Front Less-Is-More Cardiologist MIЯVΛƬ #IC Michael Savage Faisal Bakaeen MD Victor Dayan Ovidio García Patrick Myers Joe Sabik Marc Ruel, MD, MPH Husam H Balkhy Gianluca Torregrossa Jacqueline Tamis-Holland Sripal Bangalore Giuseppe Biondi-Zoccai Mamas A. Mamas Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 David L. Fischman Dr. Deepak L. Bhatt Binita Shah Sandeep Nathan, MD, MSc Dr Roxana Mehran Angioplasty.Org John Mandrola, MD The Patient-Centered Outcomes Research Institute nhlbi That is such an important point. Indeed, even in ISCHEMIA, the more symptomatic patients with daily or weekly angina derived substantially more benefit in terms of angina relief and improvement in quality of life.

Rebecca Haraf OHSU Cardiology Fellowship wrote this detailed review on cardiac myosin inhibitors #CMI in #HCM in CJC Journals onlinecjc.ca/article/S0828-… Check out a whole series of reviews covering all aspects of HCM onlinecjc.ca/inpress #CardioTwitter

Excited to share our latest review article on M-TEER, advancing treatment options for degenerative MR, under the mentorship of Dr. Golwala Harsh Golwala . Grateful for the opportunity to contribute. OHSU Cardiology Fellowship Ahmed Teebi, MD MPH🗝️ 🔗 interventional.theclinics.com/article/S2211-…

Our fantastic second year fellow, Katie Lutz, presenting her research proposal at OHSU Knight Cardio research seminar. Mentored by Drs. Jeffrey Marbach and Nabil Alkayed. Congratulations!! 👏🏼🔝✨

In the first US trial evaluating a drug-coated balloon for coronary in-stent restenosis, we found that the Agent paclitaxel balloon reduced target lesion failure by > 40% compared with conventional angioplasty. Now FDA approved. Published in JAMA now: jamanetwork.com/journals/jama/…

Congratulations to Eric Secemsky MD MSc on his promotion to Associate Professor of Medicine Harvard Medical School! We are excited to see what this new chapter will bring.

Presenting at #ACC24 Interventional Cardiology section with Katie Lutz : We discuss the time-varying cardiovascular impact of complete revascularization vs. culprit-only revascularization in older adults. Grateful to Dr. Marbach Jeffrey Marbach for his mentorship. OHSU Cardiology Fellowship

Dr. Katie Lutz presenting research on complete vs culprit vessel revascularization among elderly patients with MI at #ACC24. Congratulations to her, Dr. Salman Zahid and their mentor Dr. Jeffrey Marbach✨🫀

Drs. Karla Asturias, MD and Katie Lutz presenting a challenging case of 5-FU cardiotoxicity at #ACC24 🫀🫀🫀mentored by Jeffrey Marbach

First DRAIN-HF enrollment in Oregon! Congratulations to Jeffrey Marbach and the team at OHSU Knight Cardio on enrolling your first patient in this groundbreaking study for patients with acute decompensated #heartfailure. #Aortix #cardiorenalsyndrome #diureticresistance #clinicaltrials

First 2 commercial #RDN cases in the NW USA. Thank you Medtronic and OHSU Knight Cardio

Congratulations ⁦Salman Zahid⁩ Time-Varying Cardiovascular Effects of Complete Versus Culprit Vessel Revascularization Among Older Adults With Myocardial Infarction - ScienceDirect. ⁦OHSU Cardiology Fellowship⁩ sciencedirect.com/science/articl…

Almost a month into fellowship, we are so proud to have this amazing team of new OHSU Knight Cardio fellows. We are really excited to keep learning with you✨🫀🤓

Please to share our 📜under the mentorship of Jeffrey Marbach , We explores how complete revascularization compares to culprit-only revascularization in older adults (75+) in terms of restricted mean survival time. 🔗jacc.org/doi/10.1016/j.… OHSU Cardiology Fellowship